JFDA Approves Groundbreaking Clinical Trial for Cancer Treatment
The Jordan Food and Drug Administration (JFDA) has approved a pioneering clinical trial, the first of its kind in the Kingdom, to treat patients diagnosed with relapsed or refractory acute lymphoblastic leukemia in children and adults, and relapsed or refractory lymphoma in adults, using Chimeric Antigen Receptor T-cell (CAR-T) therapy. According to a statement released … Read more